Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion

Neuroscience Letters

Volumn 453, Issue 3, 2009, Pages 204-209

  Gu, Haigang ^a,c   Long, Dahong ^a   Song, Cunxian ^b   Li, Xiaobin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Alzheimer's disease; Cholinergic neurons; Learning and memory; Microspheres; Recombinant human nerve growth factor

Indexed keywords

MICROSPHERE; RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN FORNIX; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FIMBRIA; FOREBRAIN; IMMUNOHISTOCHEMISTRY; MALE; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM;

ALZHEIMER DISEASE; ANIMALS; CELL SURVIVAL; CHOLINE O-ACETYLTRANSFERASE; FORNIX, BRAIN; HUMANS; MALE; MAZE LEARNING; MEMORY; MICROSPHERES; NERVE GROWTH FACTOR; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 61849127257     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.02.027     Document Type: Article

References (21)

1. Aubert-Pouessel A., Venier-Julienne M.C., Clavreul A., Sergent M., Jollivet C., Montero-Menei C.N., Garcion E., Bibby D.C., Menei P., and Benoit J.P. In vitro study of GDNF release from biodegradable PLGA microspheres. J. Control Release 95 (2004) 463-475
2. Batchelor P.E., Armstrong D.M., Blaker S.N., and Gage F.H. Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection. J. Comp. Neurol. 284 (1989) 187-204
3. Castellani R.J., Zhu X., Lee H.G., Moreira P.I., Perry G., and Smith M.A. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?. Expert Rev. Neurother. 7 (2007) 473-485
4. Clavreul A., Sindji L., Aubert-Pouessel A., Benoit J.P., Menei P., and Montero-Menei C.N. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts. Eur. J. Pharm. Biopharm. 63 (2006) 221-228
5. Freiberg S., and Zhu X.X. Polymer microspheres for controlled drug release. Int. J. Pharm. 282 (2004) 1-18
6. Frielingsdorf H., Thal L.J., and Pizzo D.P. The septohippocampal cholinergic system and spatial working memory in the Morris water maze. Behav. Brain Res. 168 (2006) 37-46
7. Geula C., Nagykery N., Nicholas A., and Wu C.K. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67 (2008) 309-318
8. Gu H., Song C., Long D., Mei L., and Sun H. Controlled release of recombinant human nerve growth factor (rhNGF) from poly[(lactic acid)-co-(glycolic acid)] microspheres for the treatment of neurodegenerative disorders. Polym. Int. 56 (2007) 1272-1280
9. Gutierrez H., Miranda M.I., and Bermudez-Rattoni F. Learning impairment and cholinergic deafferentation after cortical nerve growth factor deprivation. J. Neurosci. 17 (1997) 3796-3803
10. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6 (1986) 2155-2162
11. Hoyer S., and Riederer P. Alzheimer disease-no target for statin treatment. A mini review. Neurochem. Res. 32 (2007) 695-706
12. Mahoney M.J., and Saltzman W.M. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J. Pharm. Sci. 85 (1996) 1276-1281
13. Markowska A.L., Koliatsos V.E., Breckler S.J., Price D.L., and Olton D.S. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 14 (1994) 4815-4824
14. Menei P., Montero-Menei C., Venier M.C., and Benoit J.P. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin. Drug Deliv. 2 (2005) 363-376
15. Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., and Sadovnick A.D. Diagnosis and treatment of dementia. 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178 (2008) 548-556
16. Pean J.M., Menei P., Morel O., Montero-Menei C.N., and Benoit J.P. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials 21 (2000) 2097-2101
17. Tuszynski M.H. Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 21 (2007) 179-189
18. Tuszynski M.H., and Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog. Brain Res. 146 (2004) 441-449
19. Tuszynski M.H., Thal L., Pay M., Salmon D.P., Bakay H.S.U.R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., and Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11 (2005) 551-555
20. Wilkins C.H., Grant E.A., Schmitt S.E., McKeel D.W., and Morris J.C. The neuropathology of Alzheimer disease in African American and white individuals. Arch. Neurol. 63 (2006) 87-90
21. Xuan A.G., Long D.H., Gu H.G., Yang D.D., Hong L.P., and Leng S.L. BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix. Neurosci. Lett. 440 (2008) 331-335